Effective Strategies For Treating Pandas Disorder

PANDAS, or Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections, is a rare condition that involves sudden and dramatic changes in a child's personality, behaviour, and movement following a streptococcal infection. While most people with strep infections fully recover, PANDAS causes children to exhibit behaviours similar to obsessive-compulsive disorder (OCD) and Tourette syndrome, interfering with their daily lives. The condition is likely to recur if the child contracts strep again, so it is important to treat the infection and manage its symptoms.

Antibiotics to treat the underlying strep infection

Antibiotics are a key treatment option for PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections). The goal of antibiotic treatment is to eliminate the underlying strep infection, thereby allowing the PANDAS symptoms to subside.

The first step in antibiotic treatment is to confirm the presence of a strep infection through a throat culture or blood test. If the throat culture is positive, a single course of antibiotics is usually sufficient to eradicate the infection. In the case of a negative throat culture, it is important to rule out other possible sources of infection, such as sinus infections or rare cases of strep bacteria in the anus, vagina, or urethral opening of the penis. These infections may require a longer course of antibiotic treatment.

The choice of antibiotic depends on the type of infection. Beta-lactam antibiotics, including penicillin, amoxicillin (including Augmentin), and cephalosporins, are the most effective for Group A Streptococcal (GAS) infections. Other effective antibiotics for GAS include erythromycin, azithromycin, and clindamycin. However, regional resistance to certain antibiotics should be considered when selecting the appropriate treatment.

It is important to note that antibiotics are not a cure for PANDAS but rather a temporary measure to reduce or manage symptoms. They can help alleviate symptoms associated with brain inflammation, including OCD, anxiety, tics, and more. Additionally, prophylactic antibiotic treatment may be used to prevent symptom recurrence or exacerbation. This is particularly important for children with a history of Sydenham's chorea, rheumatic fever, or PANDAS, as they are at risk of developing more severe symptoms upon reinfection with strep.

While antibiotics play a crucial role in treating the underlying strep infection in PANDAS, they are just one aspect of a comprehensive treatment plan. Other treatments, such as intravenous immunoglobulin (IVIG) therapy and plasmapheresis, address the autoimmune response and underlying infection. Behavioral therapies, such as cognitive-behavioral therapy (CBT), are also essential in managing the neuropsychiatric symptoms of PANDAS.

Anti-inflammatories to calm the immune system

PANDAS, or Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections, is a rare disease that affects up to 1 in 200 children. It is characterised by inflammation in the brain, which can cause a range of symptoms, including OCD, anxiety, depression, and tics. While there is no cure for PANDAS, there are several treatment options available to help manage symptoms and put the disease into remission. One approach is to use anti-inflammatory medications to calm the immune system and reduce inflammation.

Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen can be beneficial for PANDAS patients, particularly during exacerbations or "mini-flares" that occur following immunotherapy. These medications can help to reduce inflammation, which is believed to have a beneficial effect on patients, assuming that PANDAS is the result of an immune system disorder. In one study, researchers found that NSAIDs given prophylactically or within 30 days of flare onset may shorten neuropsychiatric symptom duration in patients with new-onset and relapsing/remitting PANDAS. It is important to note that NSAIDs carry risks, including GI bleeding, and should be used with caution and under medical supervision.

Another anti-inflammatory treatment option is steroids, which may reduce the inflammation occurring in the child's brain. However, it is important to note that some children with PANDAS/PANS can experience a worsening of tics or aggression with the use of steroids, so it is important to discuss the potential benefits and risks with a healthcare provider.

In addition to medications, following an anti-inflammatory diet may also help to reduce inflammation. An anti-inflammatory diet includes green leafy vegetables, nuts, fatty fish, and fruits such as strawberries, blueberries, cherries, and oranges. These foods contain natural antioxidants and polyphenols, which have been linked to reduced inflammation and a lower risk of chronic diseases.

Starting treatment for PANDAS early is one of the most effective ways to manage symptoms and put the disease into remission. Early treatment can also help to minimise relapses, which tend to increase in duration and intensity with each episode. Therefore, it is important to work with a healthcare provider to determine the most appropriate treatment plan for each individual.

Cognitive behavioural therapy to help control OCD

PANDAS, or Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections, is a rare disease that affects up to 1 in 200 children. It involves the onset of Obsessive-Compulsive Disorder (OCD) or tic disorder, or both, following a streptococcal infection. The symptoms of PANDAS are usually dramatic and sudden, and can include motor or vocal tics, obsessions, compulsions, mood swings, irritability, anxiety attacks, and separation anxiety.

Cognitive-behavioral therapy (CBT) is an effective tool in the treatment of childhood-onset OCD, whether related to PANDAS or not. CBT, in combination with a selective serotonin reuptake inhibitor (SSRI) medication, is considered the best treatment for OCD symptoms. CBT for OCD uses two scientifically based techniques: exposure and response prevention (ERP) and cognitive therapy.

During ERP therapy, patients are gradually exposed to their obsessions and asked not to perform the compulsions that usually ease their anxiety and distress. This is done at the patient's pace, and the therapist should never force the patient to do anything they are uncomfortable with. The goal of ERP therapy is to help patients learn to resist their compulsions and embrace uncertainty.

Cognitive therapy helps patients understand that their brain is sending error messages. Therapists help patients learn to recognize these messages and respond to them in new ways to help control their obsessions and compulsions. This type of therapy focuses on the meanings we attach to certain experiences that we misinterpret. For example, a patient might interpret a friend passing them without acknowledgment as the friend not liking them. Cognitive therapy helps patients stand back from these thoughts, examine the evidence, and tell themselves something more realistic.

When working with children with PANDAS, CBT can be an important component of the overall treatment regimen. Treatment should involve parents (and other family members as appropriate) so that they can be taught the nature of the treatment and guided to serve as the child's at-home therapist. Treatment may be intensive (i.e. daily) or once or twice weekly.

There are several reasons why CBT may be beneficial in working with families of a child with PANDAS. Children and their family members often engage in behavioral patterns that maintain obsessive-compulsive/anxiety symptoms such as distress-reducing rituals, avoidance, and family accommodation. Such behaviors are negatively reinforcing and contribute to the strengthening of associations between feared stimuli. This may explain why some children who respond to immunomodulatory therapy continue to exhibit residual symptoms, as they have become learned behaviors. Thus, addressing these symptoms behaviorally may be promising.

In addition, the onset of PANDAS can be a remarkably difficult experience that affects family functioning. The addition of CBT may provide children and family members with tools to effectively combat and/or contend with future exacerbations.

Antidepressants to manage OCD

PANDAS, or Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections, is a rare condition that can cause dramatic and sudden changes in a child's mental health. It is characterised by the onset of obsessive-compulsive disorder (OCD), tic disorders, or both, following a streptococcal infection. While there is no lab test to diagnose PANDAS, the clinical diagnosis is based on several criteria, including the presence of OCD or tic disorders, the onset of symptoms between the ages of 3 and puberty, and a history of streptococcal infection.

Treating the underlying streptococcal infection is crucial in managing PANDAS. Antibiotics are often used to reduce inflammation in the brain and alleviate symptoms such as OCD, anxiety, and tics. However, antibiotics do not cure PANDAS but rather help manage the associated neuropsychiatric symptoms.

In addition to antibiotics, other treatments such as intravenous immunoglobulin replacement therapy (IVIG) and plasmapheresis (plasma exchange) aim to address the underlying infection and autoimmune response. Non-invasive options, such as over-the-counter anti-inflammatory drugs, can also help control inflammation.

When it comes to managing OCD symptoms specifically in PANDAS, Selective Serotonin Reuptake Inhibitors (SSRIs) are often considered. SSRIs, such as fluoxetine, fluvoxamine, sertraline, and paroxetine, can help treat OCD and anxiety symptoms. However, it is important to note that SSRIs come with a risk of side effects, including increased anxiety, agitation, and akathisia. Therefore, it is recommended to start with extremely low doses and slowly increase the dosage over time. An adequate trial of an SSRI is typically considered to be 10-12 weeks at the maximum dosage.

Additionally, cognitive-behavioural therapy (CBT) or exposure and response prevention (ERP) may be beneficial in conjunction with medical interventions like antibiotics and IVIG.

Intravenous immunoglobulin therapy to boost the immune system

Intravenous immunoglobulin (IVIG) therapy is a treatment option for PANDAS, which stands for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections. PANDAS is a rare disease that affects up to 1 in 200 children and is characterised by the sudden onset of obsessive-compulsive disorder (OCD), tic disorder, or both, following a streptococcal infection.

IVIG therapy is a treatment option that can address the underlying infection and autoimmune reaction that causes PANDAS. It involves the use of an immunoglobulin solution to treat immune deficiencies and other medical conditions. Immunoglobulin, or Ig, refers to the liquid plasma component of blood that contains antibodies. These antibodies play a crucial role in the immune system by correcting misdirected immune processes and enhancing the destruction of bacteria, certain viruses, and other pathogens.

IVIG therapy aims to replenish sufficient amounts of IgG antibodies, which are the most abundant type of immunoglobulin. This helps to passively neutralise or opsonise a broad spectrum of infectious pathogens and can also elicit an active immune response by activating various immune cells. The therapy can be administered either intravenously (IVIG) or subcutaneously (SCIG), with IVIG being the more common route.

The dosage and frequency of IVIG therapy depend on the patient's condition and response to treatment. Typically, IVIG is administered at replacement doses of 400 to 600 mg/kg per month for primary immunodeficiencies. For immunomodulation in autoimmune disorders, higher doses ranging from 1000 to 3000 mg/kg of body weight are required. The optimal dosage, duration, and frequency are determined based on the patient's needs and response to treatment.

While IVIG therapy is generally well-tolerated, side effects can occur, especially during the first dose or when changing brands. These side effects can include mild reactions such as skin irritation, itching, and fatigue. More serious but rare side effects include severe headaches, dyspnea, thromboembolic events, and anaphylaxis. It is important to monitor patients carefully during the initial infusions and in high-risk categories to promptly address any adverse reactions.

The cost of IVIG therapy can be high, with a single treatment costing around $10,000 in the United States. However, health insurance may cover some or all of the expenses. IVIG therapy is often a lifelong treatment for chronic diseases with no cure, and its use should be carefully evaluated and monitored by a qualified healthcare team.

Frequently asked questions